Literature DB >> 17206755

Hepatitis B virus morphogenesis.

Volker Bruss1.   

Abstract

The hepatitis B virus (HBV) particle consists of an envelope containing three related surface proteins and probably lipid and an icosahedral nucleocapsid of approximately 30 nm diameter enclosing the viral DNA genome and DNA polymerase. The capsid is formed in the cytosol of the infected cell during packaging of an RNA pregenome replication complex by multiple copies of a 21-kDa C protein. The capsid gains the ability to bud during synthesis of the viral DNA genome by reverse transcription of the pregenome in the lumen of the particle. The three envelope proteins S, M, and L shape a complex transmembrane fold at the endoplasmic reticulum, and form disulfide-linked homo- and heterodimers. The transmembrane topology of a fraction of the large envelope protein L changes post-translationally, therefore, the N terminal domain of L (preS) finally appears on both sides of the membrane. During budding at an intracellular membrane, a short linear domain in the cytosolic preS region interacts with binding sites on the capsid surface. The virions are subsequently secreted into the blood. In addition, the surface proteins can bud in the absence of capsids and form subviral lipoprotein particles of 20 nm diameter which are also secreted.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17206755      PMCID: PMC4065877          DOI: 10.3748/wjg.v13.i1.65

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  139 in total

1.  Polymerase gene products of hepatitis B viruses are required for genomic RNA packaging as wel as for reverse transcription.

Authors:  R C Hirsch; J E Lavine; L J Chang; H E Varmus; D Ganem
Journal:  Nature       Date:  1990-04-05       Impact factor: 49.962

2.  Hepatitis B virus capsid-like particles can display the complete, dimeric outer surface protein C and stimulate production of protective antibody responses against Borrelia burgdorferi infection.

Authors:  Claudia Skamel; Martin Ploss; Bettina Böttcher; Thomas Stehle; Reinhard Wallich; Markus M Simon; Michael Nassal
Journal:  J Biol Chem       Date:  2006-04-18       Impact factor: 5.157

3.  The N-terminal (pre-S2) domain of a hepatitis B virus surface glycoprotein is translocated across membranes by downstream signal sequences.

Authors:  B E Eble; V R Lingappa; D Ganem
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

4.  Novel N-terminal amino acid sequence required for retention of a hepatitis B virus glycoprotein in the endoplasmic reticulum.

Authors:  K Kuroki; R Russnak; D Ganem
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

5.  Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification.

Authors:  J Summers; P M Smith; A L Horwich
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

6.  A recombinant hepatitis B core antigen polypeptide with the protamine-like domain deleted self-assembles into capsid particles but fails to bind nucleic acids.

Authors:  A Gallina; F Bonelli; L Zentilin; G Rindi; M Muttini; G Milanesi
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

7.  Multiple topogenic sequences determine the transmembrane orientation of the hepatitis B surface antigen.

Authors:  B E Eble; D R MacRae; V R Lingappa; D Ganem
Journal:  Mol Cell Biol       Date:  1987-10       Impact factor: 4.272

8.  Identification of compounds that inhibit the interaction between core and surface protein of hepatitis B virus.

Authors:  M Asif-Ullah; Kyoung-Jae Choi; Kyung-Il Choi; Yong-Joo Jeong; Yeon Gyu Yu
Journal:  Antiviral Res       Date:  2006-02-03       Impact factor: 5.970

9.  Hepatitis B virus produced by transfected Hep G2 cells causes hepatitis in chimpanzees.

Authors:  G Acs; M A Sells; R H Purcell; P Price; R Engle; M Shapiro; H Popper
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

10.  An in vitro fluorescence screen to identify antivirals that disrupt hepatitis B virus capsid assembly.

Authors:  Stephen J Stray; Jennifer M Johnson; Benjamin G Kopek; Adam Zlotnick
Journal:  Nat Biotechnol       Date:  2006-02-12       Impact factor: 54.908

View more
  102 in total

Review 1.  The underlying mechanisms for the "isolated positivity for the hepatitis B surface antigen (HBsAg)" serological profile.

Authors:  Robério Amorim de Almeida Pondé
Journal:  Med Microbiol Immunol       Date:  2010-05-11       Impact factor: 3.402

2.  The lytic transcriptome of Kaposi's sarcoma-associated herpesvirus reveals extensive transcription of noncoding regions, including regions antisense to important genes.

Authors:  Sanjay Chandriani; Yiyang Xu; Don Ganem
Journal:  J Virol       Date:  2010-06-09       Impact factor: 5.103

Review 3.  Microvesicles and viral infection.

Authors:  David G Meckes; Nancy Raab-Traub
Journal:  J Virol       Date:  2011-10-05       Impact factor: 5.103

4.  Novel functions of prototype foamy virus Gag glycine- arginine-rich boxes in reverse transcription and particle morphogenesis.

Authors:  Erik Müllers; Tobias Uhlig; Kristin Stirnnagel; Uwe Fiebig; Hanswalter Zentgraf; Dirk Lindemann
Journal:  J Virol       Date:  2010-11-24       Impact factor: 5.103

5.  Subviral Hepatitis B Virus Filaments, like Infectious Viral Particles, Are Released via Multivesicular Bodies.

Authors:  Bingfu Jiang; Kiyoshi Himmelsbach; Huimei Ren; Klaus Boller; Eberhard Hildt
Journal:  J Virol       Date:  2015-12-30       Impact factor: 5.103

6.  Assembly of hepatitis B virus envelope proteins onto a lentivirus pseudotype that infects primary human hepatocytes.

Authors:  Ning Chai; Ho Eun Chang; Emmanuelle Nicolas; Severin Gudima; Jinhong Chang; John Taylor
Journal:  J Virol       Date:  2007-08-01       Impact factor: 5.103

7.  Discovery and Mechanistic Study of Benzamide Derivatives That Modulate Hepatitis B Virus Capsid Assembly.

Authors:  Shuo Wu; Qiong Zhao; Pinghu Zhang; John Kulp; Lydia Hu; Nicky Hwang; Jiming Zhang; Timothy M Block; Xiaodong Xu; Yanming Du; Jinhong Chang; Ju-Tao Guo
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

8.  Domains of the Hepatitis B Virus Small Surface Protein S Mediating Oligomerization.

Authors:  Sascha Suffner; Nadine Gerstenberg; Maria Patra; Paula Ruibal; Ahmed Orabi; Michael Schindler; Volker Bruss
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

9.  Fine mapping of pre-S sequence requirements for hepatitis B virus large envelope protein-mediated receptor interaction.

Authors:  Andreas Schulze; Alexa Schieck; Yi Ni; Walter Mier; Stephan Urban
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

10.  DDX3 DEAD-Box RNA helicase inhibits hepatitis B virus reverse transcription by incorporation into nucleocapsids.

Authors:  Haifeng Wang; Seahee Kim; Wang-Shick Ryu
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.